Rajanish Giri

InstitutionIndian Institute of Technology Mandi
AddressKamand
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in Spetember 2020 and June 2021
    All Publications
    Bar chart showing 34 publications over 11 distinct years, with a maximum of 5 publications in 2017 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shree P, Mishra P, Kumar P, Pandey H, Giri R, Chaube R, Garg N, Tripathi YB. In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets Mpro and TMPRSS2. J Biomol Struct Dyn. 2021 Aug 23; 1-14. PMID: 34424815.
      Citations:    Fields:    
    2. Kumar P, Bhardwaj T, Kumar A, Garg N, Giri R. One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding. J Biomol Struct Dyn. 2021 Jul 29; 1-8. PMID: 34320905.
      Citations:    Fields:    
    3. Ayatollahi SA, Sharifi-Rad J, Tsouh Fokou PV, Mahady GB, Ansar Rasul Suleria H, Krishna Kapuganti S, Gadhave K, Giri R, Garg N, Sharma R, Ribeiro D, Rodrigues CF, Reiner Ž, Taheri Y, Cruz-Martins N. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection. Front Pharmacol. 2021; 12:575877. PMID: 34267652.
      Citations: 1     
    4. Gadhave K, Kumar P, Kumar A, Bhardwaj T, Garg N, Giri R. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions. Microb Pathog. 2021 Sep; 158:105041. PMID: 34119626.
      Citations: 2     Fields:    Translation:HumansCells
    5. Kumar A, Kumar A, Kumar P, Garg N, Giri R. SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation. Curr Res Virol Sci. 2021; 2:100007. PMID: 34189489.
      Citations: 1     
    6. Kumar P, Bhardwaj T, Kumar A, Gehi BR, Kapuganti SK, Garg N, Nath G, Giri R. Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study. J Biomol Struct Dyn. 2020 Nov 12; 1-15. PMID: 33179586.
      Citations: 4     Fields:    
    7. Khrustalev VV, Giri R, Khrustaleva TA, Kapuganti SK, Stojarov AN, Poboinev VV. Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses. Front Microbiol. 2020; 11:559165. PMID: 33072018.
      Citations: 5     
    8. Kumar A, Kumar P, Saumya KU, Kapuganti SK, Bhardwaj T, Giri R. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach. Expert Rev Vaccines. 2020 09; 19(9):887-898. PMID: 32815406.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    9. Giri R, Bhardwaj T, Shegane M, Gehi BR, Kumar P, Gadhave K, Oldfield CJ, Uversky VN. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses. Cell Mol Life Sci. 2021 Feb; 78(4):1655-1688. PMID: 32712910.
      Citations: 18     Fields:    Translation:HumansAnimalsCells